Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care.

ABSTRACT: Clinical applicability of rapid diagnostic test kit for SARS-CoV-2 antibodies was evaluated. The kit detected antibodies from day 9-56 of illness. IgG bands were observed up to 1: 1000 dilutions. The kit could detect 90.5% of IgG and 61.9% of IgM antibodies of mild febrile patients without pneumonia.

SUBMITTER: Ko JH 

PROVIDER: S-EPMC7348590 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature